Biologische Heilmittel Heel GmbH   Report issue

For profit Phase 2 Phase 3
Founded: Baden-Baden Germany (1936)
Status: No NME R&D (1936)

Organization Overview

First Clinical Trial
2009
NCT01066520
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (5)

diclofenac (voltaren) (1 trial)

sodium chloride (1 trial)

traumeel (5 trials)

urea (1 trial)

zeel (1 trial)

Drugs in Phase 2 Trials (1)

neurexan (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ankle Injuries (Phase 3)

Bursitis (Phase 3)

Fractures, Stress (Phase 2)

Myalgia (Phase 1)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Rotator Cuff Injuries (Phase 3)

Sprains and Strains (Phase 3)

Stress Disorders, Traumatic, Acute (Phase 2)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 6